Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 10998.154 | 0.9108 | 0.7632 | 0.7412 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 10998.154 | 0.9246 | 0.7993 | 0.7412 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 10998.154 | 0.9551 | 0.8798 | 0.7412 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 10998.154 | 0.9948 | 0.9860 | 0.7412 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 10998.154 | 0.9580 | 0.8875 | 0.7412 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 10998.154 | 1.0619 | 1.1687 | 0.7412 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 10998.154 | 0.9535 | 0.8755 | 0.7412 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 10998.154 | 0.9163 | 0.7776 | 0.7412 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0000853 | uM | 12206.154 | 0.9593 | 0.9196 | 1.0125 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.000427 | uM | 12206.154 | 0.9255 | 0.8528 | 1.0125 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.00213 | uM | 12206.154 | 0.9653 | 0.9314 | 1.0125 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0107 | uM | 12206.154 | 0.9945 | 0.9891 | 1.0125 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.0533 | uM | 12206.154 | 0.9682 | 0.9371 | 1.0125 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 0.267 | uM | 12206.154 | 0.9720 | 0.9447 | 1.0125 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 1.33 | uM | 12206.154 | 0.9111 | 0.8243 | 1.0125 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 6.67 | uM | 12206.154 | 0.9315 | 0.8646 | 1.0125 | |
MDA-MB-134-VI | HR+ | Luminal | FTase Inhibitor I | Ftase | MAPK | 33.3 | uM | 12206.154 | 0.9430 | 0.8875 | 1.0125 | |
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.000171 | uM | 12594.167 | 0.9535 | 0.9336 | 1.4099 | |
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.000853 | uM | 12594.167 | 0.9792 | 0.9704 | 1.4099 | |
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.00427 | uM | 12594.167 | 0.9518 | 0.9312 | 1.4099 | |
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.0213 | uM | 12594.167 | 0.9848 | 0.9784 | 1.4099 | |
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.107 | uM | 12594.167 | 1.0055 | 1.0078 | 1.4099 | |
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 0.533 | uM | 12594.167 | 1.0025 | 1.0035 | 1.4099 | |
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 2.67 | uM | 12594.167 | 1.0411 | 1.0579 | 1.4099 | |
MDA-MB-157 | TNBC | Basal B | FTase Inhibitor I | Ftase | MAPK | 13.3 | uM | 12594.167 | 1.0063 | 1.0089 | 1.4099 |